44K+ device recalls, 510(k) and PMA approvals, surgeon procedure volumes, hospital targeting, competitive positioning, and adverse event monitoring. The intelligence that Evaluate, Definitive HC, and IQVIA charge $330K+ for , all at from $199/month.
Evaluate (Evaluate Medtech)
Device market analytics, competitive intelligence, deal data
Definitive Healthcare
Surgeon volumes, hospital targeting, device usage estimates
IQVIA
Device market data, hospital purchasing, competitive tracking
FDA database tools (manual)
510(k), PMA, MAUDE, recalls, free but manual, no analytics
Consulting firms
Market sizing, competitive analysis, regulatory strategy
Total per year
$330K–$1.3M+(dimensions we cover)Ask in plain English. Follow up to drill deeper. One conversation replaces multiple vendor dashboards.
Device Recall Tracking (44K+ recalls)
Search the full FDA device recall database, 44K+ recalls with device type, manufacturer, classification, reason for recall, and affected product codes. Filter by Class I, II, or III. Track recall trends by category.
You ask
“Show all Class I recalls for cardiac devices in the past 3 years”
Then follow up
“Which manufacturers have the most Class I cardiac device recalls? Rank them by frequency.”
“Has this specific manufacturer’s recall rate changed year over year? Show me the trend.”
510(k) & PMA Approval Intelligence
Track new 510(k) clearances and PMA approvals by product code, applicant, decision date, or device category. Monitor the competitive pipeline and identify new entrants, approval timelines, and predicate device relationships.
You ask
“Find all 510(k) clearances for orthopedic implants in 2024”
Then follow up
“Which applicants received the most 510(k) clearances in orthopedics last year? Who’s growing fastest?”
“What’s the average time from submission to clearance for this device category?”
FAERS Device Adverse Events
25M+ adverse event reports in FAERS include medical device events, device malfunction, patient outcomes, manufacturer, and event type. Identify safety signals, track trend changes by quarter, and benchmark against comparable devices.
You ask
“Show adverse events for this specific device model, outcomes and event types”
Then follow up
“Compare the adverse event profile of this device vs the two leading competitors. Which has more serious outcomes?”
“Is the adverse event rate for this device trending up or down over the past 8 quarters?”
Surgeon Procedure Volume
Medicare utilization data shows who performs the most procedures by CPT code, geography, and specialty. Identify high-volume surgeons for device targeting, territory planning, and KOL identification, no proprietary estimates needed.
You ask
“Find the top 20 knee replacement surgeons in Texas by procedure volume”
Then follow up
“For the top knee replacement surgeon in Dallas, what other procedures do they perform? What’s their full profile?”
“Which orthopedic surgical groups in Texas have the highest total volume across hip and knee replacements?”
Hospital Targeting
6,100+ hospital profiles with CMS financials, bed counts, specialty services, quality scores, and provider rosters. Identify the highest-volume facilities for any procedure type and build targeted account lists.
You ask
“Which hospitals in Florida do the most cardiac surgeries?”
Then follow up
“For the top 10 cardiac hospitals in Florida, show me their financial profile, revenue, margins, bed count.”
“Which of these hospitals are part of large IDNs? Who makes device purchasing decisions?”
Open Payments (Device Payments)
Every payment from medical device companies to physicians, by company, product, amount, and nature of payment. Identify surgeon relationships, speaker bureau members, and consulting arrangements. Map your competitors’ KOL networks.
You ask
“Show all payments from Stryker to orthopedic surgeons in 2023. Who got the most?”
Then follow up
“Cross-reference Stryker’s top-paid orthopedic surgeons with their procedure volumes. Are they also high-volume implant users?”
“Which device companies are paying the most to spine surgeons in California?”
Clinical Trial Intelligence
577K clinical trials including device trials. Find active trials by device type, condition, sponsor, or site. Track competitive device development pipelines, enrollment status, and which facilities are running trials for your category.
You ask
“Find active device trials for robotic surgery systems”
Then follow up
“Which hospitals are running the most robotic surgery trials? Which are the key trial sites?”
“Who are the principal investigators for robotic surgery trials? Are any of them also high-volume procedure surgeons?”
Provider Network Mapping
2.6M providers linked to 273K facilities via NPI taxonomy. Map which surgeons are affiliated with which hospitals, track specialty distribution by geography, and identify competitive account overlap.
You ask
“Which surgeons at Memorial Hospital use our competitor’s device category?”
Then follow up
“Show me all orthopedic surgeons affiliated with this hospital system. How many are high-volume?”
“Which surgeons have affiliations at multiple hospitals in our territory?”
Not clean, SaaS-y queries. These are the messy, multi-domain questions a device team actually asks on Monday morning, each one normally means Evaluate plus Definitive plus Open Payments plus a regulatory analyst.
“Find the top 50 knee surgeons in our territory. Cross-reference with Open Payments, who’s already taking competitor money, who’s unattached, and which unattached surgeons have rising Medicare volume?”
“Pull all Class I recalls in our device category over the past 12 months, map each to its manufacturer, and overlay the MAUDE event trend for that product. Which competitor is about to face an MDL?”
“Compare the adverse event profile of our device against the two leading competitors over the last 8 quarters. Which specific failure modes are we worse on, and which are accelerating for them?”
“Which hospitals in our region have the highest orthopedic procedure volumes, IDN affiliation, solid operating margin, and no current system-wide competitor contract? Rank as acquisition targets.”
“Show every 510(k) clearance in our device category over the past 12 months. Who’s behind each applicant, PE-backed, established, or new entrant, and are any of them already in active trials?”
“Map our primary competitor’s KOL network. Which surgeons did they flip in the past 24 months, where, and what was the payment trajectory before the switch?”
Medistill vs Evaluate
Evaluate leads in proprietary device market sizing and deal data. We add surgeon volumes, recall tracking, adverse events, and Open Payments they don't cover.
See full comparison →Medistill vs Definitive Healthcare
Definitive leads in hospital targeting and device usage estimates. We add 44K recalls, adverse events, Open Payments, compliance, and litigation they don't cover.
See full comparison →Medistill replaces:
We don't replace:
Medistill covers the data and intelligence layer. It complements proprietary data platforms, not replaces them.
Pricing
Pro $199 / 500 credits · Business $499 / 1,500 credits · Unlimited $999 ($9,990/yr) · Team from $599/seat
Full access to all 2,000+ datasets. No per-query fees. 1 credit per entity processed.
No credit card required. Expires in 15 days.